Quidel Corporation Helping Women and Their Families Live Healthy Lives, discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for the detection of medical conditions and illnesses.
Quidel to Present at the 29th Annual Piper Jaffray Healthcare Conference Wed, 15 Nov 2017 21:05:00 +0000 Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the 29th Annual Piper Jaffray Healthcare Conference, to be held at the Lotte New York Palace hotel in New York, New York on Tuesday, November 28, 2017.
ETFs with exposure to Quidel Corp. : November 8, 2017 Wed, 08 Nov 2017 23:29:38 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Quidel Corp. Here are 5 ETFs with the largest exposure to QDEL-US. Comparing the performance and risk of Quidel Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
Quidel Corp. :QDEL-US: Earnings Analysis: Q3, 2017 By the Numbers : November 7, 2017 Tue, 07 Nov 2017 13:06:02 +0000 Categories: Yahoo FinanceGet free summary analysis Quidel Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Quidel Corp. – Bio-Rad Laboratories, Inc. Class B, OraSure Technologies, Inc., Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc. and PerkinElmer, Inc. (BIO.B-US, OSUR-US, DHR-US, BDX-US, TMO-US ... Read more
(Read more...)
Quidel Corp. – Value Analysis (NASDAQ:QDEL) : November 6, 2017 Mon, 06 Nov 2017 18:16:23 +0000 Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Quidel Corp. a score of 22. Our analysis is based on comparing Quidel Corp. with the following peers – Meridian Bioscience, Inc., ERBA Diagnostics, Inc., Bio-Rad Laboratories, Inc. Class B, OraSure Technologies, Inc., Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc. and PerkinElmer, Inc. (VIVO-US, ... Read more
(Read more...)
Quidel Corp. breached its 50 day moving average in a Bearish Manner : QDEL-US : November 3, 2017 Fri, 03 Nov 2017 12:35:53 +0000 Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Quidel Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish 50 ... Read more
(Read more...)
Quidel reports 3Q loss Wed, 01 Nov 2017 22:39:58 +0000 The San Diego-based company said it had a loss of 16 cents per share. The medical diagnostics company posted revenue of $50.9 million in the period, falling short of Street forecasts. Three analysts surveyed ...
Quidel Reports Third Quarter 2017 Financial Results Wed, 01 Nov 2017 20:10:00 +0000 Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the third quarter ended September 30, 2017.
Quidel Receives FDA Clearance for Its Point-of-Care Sofia® Lyme FIA Mon, 23 Oct 2017 12:30:00 +0000 Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received 510 clearance from the United States Food and Drug Administration to market its Sofia Lyme FIA for the rapid differential detection of human IgM and IgG antibodies to Borrelia burgdorferi from serum and plasma specimens from patients ...
Quidel Receives FDA Clearance for Its Solana® RSV + hMPV Assay Tue, 17 Oct 2017 12:30:00 +0000 Quidel Corporation , a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it has received clearance from the United States Food and Drug Administration to market its Solana® respiratory syncytial virus + human metapneumovirus Assay for the detection of nucleic acids isolated from nasal and nasopharyngeal swabs from patients ...
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.
Accum/Dist: 1.20 (median winner: 1.53)
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.